Not checkedNot checked for notices yet.
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
López Longo J, Muñoz-Jiménez A, Velloso-Feijoo M L and 4 more
Journal of Translational Medicine · 2010
doi:10.1186/1479-5876-8-s1-p70 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease of unknown etiology. The evolution of the disease is unpredictable. Most patients follow a chronic course and have flare-ups or exacerbations, with a number of hospital admissions.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.